Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation

View source ↗

Summary

A registry study evaluating FARAVIEW technology (OPAL HDx mapping system) used with the FARAWAVE NAV ablation catheter for atrial fibrillation; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation, Pulsed Field Ablation | Status: ACTIVE_NOT_RECRUITING